ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 107 filers reported holding ERASCA INC in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $71,893 | -35.1% | 36,494 | -9.0% | 0.04% | -33.3% |
Q2 2023 | $110,745 | +76.0% | 40,125 | +92.0% | 0.07% | +88.6% |
Q1 2023 | $62,915 | -49.6% | 20,902 | -27.8% | 0.04% | -46.2% |
Q4 2022 | $124,731 | -25.8% | 28,940 | +34.7% | 0.06% | -3.0% |
Q3 2022 | $168,000 | +41.2% | 21,487 | +0.7% | 0.07% | +52.3% |
Q2 2022 | $119,000 | +20.2% | 21,337 | +85.0% | 0.04% | 0.0% |
Q1 2022 | $99,000 | -47.9% | 11,532 | -5.6% | 0.04% | -38.9% |
Q4 2021 | $190,000 | – | 12,213 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |